ARCHIVES

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 42 | November 11, 2011

Download PDF Visit The Full Archive

Related Articles

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

With workload Up, Oncology Division To Add More Staff

August 2, 1996